![Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation: Molecular Therapy - Nucleic Acids Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/6f3ca842-4eec-4136-ab86-6f4b1348b488/gr1_lrg.jpg)
Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation: Molecular Therapy - Nucleic Acids
![Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bc8af0e3-82f3-4fcc-86c2-66b5ce842dcb/jnc14806-fig-0002-m.jpg)
Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library
![Fast kinetics of environmentally induced α-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity | Scientific Reports Fast kinetics of environmentally induced α-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-75361-6/MediaObjects/41598_2020_75361_Fig8_HTML.png)
Fast kinetics of environmentally induced α-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity | Scientific Reports
![Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease | Pharmacological Reviews Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207/F2.large.jpg)
Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease | Pharmacological Reviews
![Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/42e39746-75ca-4336-98d2-0de89a429bf3/jnc13449-fig-0002-m.jpg)
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library
![Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking - ScienceDirect Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S089662732100862X-fx1.jpg)
Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking - ScienceDirect
![Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301462221002192-ga1.jpg)
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect
![α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease | Future Medicinal Chemistry α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc-2017-0016/asset/images/medium/figure1.gif)
α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease | Future Medicinal Chemistry
![A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS](https://www.pnas.org/cms/10.1073/pnas.1610586114/asset/afe8ed1a-444e-4bb0-8462-03f9a6c4aa16/assets/graphic/pnas.1610586114fig06.jpeg)
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
![α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1570963919300457-gr1.jpg)
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect
![Models of α-synuclein aggregation in Parkinson's disease | Acta Neuropathologica Communications | Full Text Models of α-synuclein aggregation in Parkinson's disease | Acta Neuropathologica Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40478-014-0176-9/MediaObjects/40478_2014_Article_176_Fig1_HTML.jpg)
Models of α-synuclein aggregation in Parkinson's disease | Acta Neuropathologica Communications | Full Text
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian Synoicum prunum | Journal of Natural Products
![IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease](https://www.mdpi.com/ijms/ijms-21-08666/article_deploy/html/images/ijms-21-08666-g001.png)
IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease
![Life | Free Full-Text | Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States? Life | Free Full-Text | Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?](https://www.mdpi.com/life/life-10-00289/article_deploy/html/images/life-10-00289-g001.png)
Life | Free Full-Text | Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?
![PDF] Preventing α-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins. | Semantic Scholar PDF] Preventing α-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/52c20e9996b01daa069b0f9e3eb224d0787e524b/13-Figure2-1.png)